The newly identified TAB3–NF-κB–Survivin axis provides new insight into the underlying mechanisms of CRC invasion and metastasis, evidence of a valuable prognostic biomarker in CRC and a rationale for treatment of metastatic CRC. Here, NFKB1 is linked to colorectal carcinoma.